Phase II trial of oral gimatecan in adults with recurrent glioblastoma

被引：0
|
作者：
Hu, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Wen, P. Y. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Abrey, L. E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Fadul, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Drappatz, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Salem, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Amato, A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Carminati, P. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Supko, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Hochberg, F. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Massachusetts Gen Hosp, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02114 USA
[2] Brigham & Womens Canc Ctr, Dana Farber Canc Inst, Boston, MA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[5] Sigma Tau Res Inc, Gaithersburg, MD USA
[6] Sigma Tau Ind Farmaceut Reiunite SpA, Pomezia, Italy
[7] Harvard Univ, Ctr Canc, Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2009
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.
    Bota, D. A.
    Eroglu, Z.
    Reardon, D. A.
    Fu, B. D.
    Norfleet, J.
    Desjardins, A.
    Linskey, M. E.
    Peters, K.
    Friedman, H. S.
    Vredenburgh, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] PHASE I/II ADAPTIVE RANDOMIZED TRIAL OF VORINOSTAT, ISOTRETINOIN, AND CARBOPLATIN IN ADULTS WITH RECURRENT GLIOBLASTOMA MULTIFORME - RESULTS OF THE PHASE I ARM
    Puduvalli, Vinay K.
    Prado, Marta Penas
    Hess, Kenneth R.
    Hunter, Kathy
    Ictech, Sandra
    Groves, Morris D.
    Gilbert, Mark R.
    Liu, Vivien
    Conrad, Charles A.
    de Groot, John
    Loghin, Monica E.
    Colman, Howard
    Levin, Victor A.
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2011, 13 : 49 - 49
  • [43] PHASE 1 TRIAL OF BEVACIZUMAB PLUS TPI 287 IN ADULTS WITH RECURRENT GLIOBLASTOMA (GBM)
    Conrad, Charles
    Yung, W. K. Alfred
    deGroot, John
    Gilbert, Mark
    Loghin, Monica
    Penas-Prado, Marta
    Tremont, Ivo
    Silberman, Sandra
    Picker, Donald
    NEURO-ONCOLOGY, 2013, 15 : 106 - 106
  • [44] Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
    Pecorelli, S.
    Ray-Coquard, I.
    Tredan, O.
    Colombo, N.
    Parma, G.
    Tisi, G.
    Katsaros, D.
    Lhomme, C.
    Lissoni, A. A.
    Vermorken, J. B.
    du Bois, A.
    Poveda, A.
    Frigerio, L.
    Barbieri, P.
    Carminati, P.
    Brienza, S.
    Guastalla, J. P.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 759 - 765
  • [45] Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
    Cai, Xuezhu
    Chandra, Vyshak
    Ou, Yangming
    Emblem, Kyrre E.
    Muzikansky, Alona
    Evans, John
    Kalpathy-Cramer, Jayashree
    Dietrich, Jorg
    Chi, Andrew S.
    Wen, Patrick Y.
    Rosen, Bruce R.
    Batchelor, Tracy
    Gerstner, Elizabeth Robins
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] A RANDOMIZED PHASE II TRIAL OF VANDETANIB (ZD6474) IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE IN ADULTS WITH RECURRENT GLIOBLASTOMA
    McNeill, Katharine
    Iwamoto, Fabio
    Kreisl, Teri
    Sul, Joohee
    Shih, Joanna
    Fine, Howard
    NEURO-ONCOLOGY, 2014, 16
  • [47] A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS
    Puduvalli, Vinay
    Wu, Jing
    Yuan, Ying
    Armstrong, Terri
    Wu, Jimin
    Giglio, Pierre
    Xu, Jihong
    Colman, Howard
    Walbert, Tobias
    Raizer, Jeffrey
    Groves, Morris
    Iwamoto, Fabio
    Tran, David
    Avgeropoulos, Nicholas
    Paleologos, Nina
    Fink, Karen
    Peereboom, David
    Chamberlain, Marc
    Merrell, Ryan
    Penas-Prado, Marta
    Yung, W. K. Alfred
    Gilbert, Mark
    NEURO-ONCOLOGY, 2018, 20 : 13 - 13
  • [48] Phase II study of Dovitinib in recurrent glioblastoma
    Mayur Sharma
    Cathy Schilero
    David M. Peereboom
    Brian P. Hobbs
    Paul Elson
    Glen H. J. Stevens
    Keith McCrae
    Andrew B. Nixon
    Manmeet S. Ahluwalia
    Journal of Neuro-Oncology, 2019, 144 : 359 - 368
  • [49] Phase II study of Dovitinib in recurrent glioblastoma
    Sharma, Mayur
    Schilero, Cathy
    Peereboom, David M.
    Hobbs, Brian P.
    Elson, Paul
    Stevens, Glen H. J.
    McCrae, Keith
    Nixon, Andrew B.
    Ahluwalia, Manmeet S.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 144 (02) : 359 - 368
  • [50] Axitinib for the treatment of recurrent glioblastoma - early results from a randomized phase II trial
    Duerinck, J.
    Du Four, S.
    Van Binst, A.
    Everaert, H.
    D'haens, J.
    Neyns, B.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S791 - S791
12345